Labshake search
Citations for Stemcell Technologies :
151 - 200 of 1147 citations for Human PDGF alpha receptor PDGFRA qPCR Primer Pair since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Pathology 2022Quote: Human biopsies were placed in PneumaCult medium (Stemcell Technologies) and sent for infection immediately ...
-
bioRxiv - Cancer Biology 2022Quote: ... Human HSPCs were expanded in StemSpan SFEM (StemCell Technologies) with 1% streptomycin/penicillin ...
-
bioRxiv - Cell Biology 2020Quote: Human CB CD34+ cells were purchased from STEMCELL Technologies GmbH (Cologne ...
-
bioRxiv - Immunology 2020Quote: ... and the EasySep human monocyte isolation kit (StemCell Technologies) with equivalent results ...
-
bioRxiv - Immunology 2023Quote: Frozen human PBMCs from 5 healthy donors (Stemcell Technologies, Cat# 70025.2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and CD28 (ImmunoCult human T cell activator, StemCell Technologies) in total volume of 200 μl complete RPMI medium in a 96-well U bottom plate in the presence of either DMSO or soquelitinib for 48 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... and analyzed by STEMvision™ Human (Stem Cell Technologies).
-
bioRxiv - Microbiology 2023Quote: ... The RosetteSep™ Human Monocyte Enrichment Cocktail (STEMCELL Technologies) was used to purify monocytes from the PBMCs ...
-
bioRxiv - Immunology 2023Quote: Human PBMCs were obtained from Stemcell Technologies (Vancouver, BC). Samples were collected from donors and anonymized prior to providing for research purposes ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1000 U recombinant human LIF (StemCell Technologies #78055). Medium was replaced daily ...
-
bioRxiv - Immunology 2024Quote: ... Human CD8+ T cells were purchased from StemCell Technologies. Viability was assessed via DAPI staining ...
-
bioRxiv - Immunology 2024Quote: ... 1.5 µg/mL anti-human CD32 antibody (STEMCELL Technologies) and 10 µg/mL anti-mouse CD16/CD32 antibody (as needed ...
-
bioRxiv - Genomics 2024Quote: Human iPSCs were maintained in mTeSR1 (StemCell Tech, 85850) or mTeSR Plus (StemCell Tech ...
-
bioRxiv - Biochemistry 2022Quote: ... with EasySep Human T cell Isolation Kit (STEMCELL Technologies). Cells were then activated for 3 days in “Complete media” (Immunocult-XF T cell expansion media (STEMCELL Technologies) ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (20 ng/mL, STEMCELL Technologies, #78006.2), human recombinant FGF (10 ng/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (2 ng/mL, STEMCELL Technologies, #78006.2), antibiotic-antimycotic (1X ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (20 ng/mL, STEMCELL Technologies, #78006.2), human recombinant FGF (10 ng/mL ...
-
bioRxiv - Immunology 2024Quote: ... 3000 IU/mL recombinant human IL-2 (Stemcell Technologies), and 15 ng/mL recombinant human IL-15 (PeproTech) ...
-
bioRxiv - Immunology 2024Quote: Human peripheral blood pan T-lymphocytes (#70024.1, StemCell Technologies) were thawed and cultured in the aforementioned T-lymphocyte media ...
-
bioRxiv - Microbiology 2024Quote: ... Human iPSCs were obtained from STEMCELL Technologies (SCTi003- A). A549 ...
-
bioRxiv - Immunology 2024Quote: Commercial frozen human PBMCs were purchased from StemCell Technologies. HG002 EBV-LCL were purchased from Coriell Institute of Medical Research and expanded for 14 days in Gibco RPMI 1640 (Thermo Fisher Scientific ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with MesenCult MSC Stimulatory Supplement (Human) (Stemcell Technologies). One thousand viable cells/4 ml of supplemented media were plated in each well of a Costar Ultra-Low Attachment 6-well plate (Corning) ...
-
bioRxiv - Bioengineering 2024Quote: Human peripheral blood pan T cells (STEMCELL Technologies #70024)
-
bioRxiv - Cancer Biology 2024Quote: ... EasySep™ Human B Cell Isolation Kit (STEMCELL technologies) were placed in transwell inserts for 6 hours at 37°C in CO2 chamber ...
-
bioRxiv - Immunology 2022Quote: Preparation of cells: Human CD4+ cells were isolated from buffy coats using EasySep™ Human CD4+ T Cell Isolation Kit (Stemcell Tech, # 17952), resuspended with complete RPMI (cRPMI ...
-
bioRxiv - Bioengineering 2021Quote: ... CD3+ T cells or CD56+CD3-NK cells were isolated from the PBMC population using the EasySep Human T Cell Isolation Kit or EasySep Human NK Cell Isolation Kit (STEMCELL Technologies, Cambridge, MA). T cells were frozen at 1-2 × 107 cells/mL and NK cells were frozen at 5 × 106 cells/mL in CryoStor CS10 (STEMCELL Technologies ...
-
bioRxiv - Immunology 2021Quote: Assays were performed on purified human classical monocytes isolated using immunomagnetic negative sorting (EasySep Direct Human Monocyte Isolation Kit, StemCell Technologies, Cambridge, MA). As we have previously described 88 ...
-
bioRxiv - Bioengineering 2023Quote: ... CD31+ EPCs were purified using a FITC-conjugated human CD31 antibody (Miltenyi, cat# 130-117-390, clone AC128) and the EasySep Human FITC Positive Selection Kit II (Stemcell Technologies, cat# 18558). Purified EPCs were seeded into collagen IV (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Bioengineering 2024Quote: The primary T cells were obtained from peripheral venous blood of a healthy human donor using the EasySep™ Direct Human T cell Isolation Kit (STEMCELL TECHNOLOGIES, #19661) following the manufacturer’s instructions ...
-
bioRxiv - Immunology 2022Quote: ... CD8+ and CD3+ T cells were isolated from PBMCs using the EasySep™ Human CD8+ T Cell Isolation Kit and EasySep™ Human T Cell Isolation Kit (both from STEMCELL Technologies), respectively ...
-
bioRxiv - Cell Biology 2023Quote: ... The middle layer containing PBMCs were then enriched for primary human NK cells (hNK) by negative selection using the EasySep Human NK Cell Enrichment Kit (StemCell Technologies, Cat# 19055), following the manufacturer’s protocol ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Immunology 2024Quote: ... neutrophils were isolated from human whole blood based on immuno-magnetic negative isolation technique using the EasySep Direct Human Neutrophil Isolation Kit (STEMCELL Technologies, Cat# 19666) described in detail in (Fan et al ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with 20ng/mL recombinant human IL-2 and 7μL/mL of ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator (Stem Cell Technologies, 10970) every week.
-
bioRxiv - Neuroscience 2022Quote: Karyotype analysis was performed using a qPCR based hPSC Genetic Analysis Kit (StemCell Technologies, #07550) and KaryoStat Karyotyping (ThermoFisher) ...
-
bioRxiv - Cancer Biology 2021Quote: Bone marrows of sacrificed mice were extracted and human cells were separated according to expression of human CD45 (EasySep™, StemCell Technologies, Vancouver, Canada). Libraries were prepared using 10X Genomics technology (see supplemental information).
-
bioRxiv - Synthetic Biology 2022Quote: Primary CD4+ and CD8+ T cells were isolated from blood of anonymous donors by negative selection using the Human CD4+ T cell isolation kit and Human CD8+ T cell isolation kit (STEMCELL Technologies #17952 and #17953). T cells were cryopreserved in RPMI1640 (UCSF cell culture core ...
-
bioRxiv - Cell Biology 2022Quote: We isolated CD34+ cells from human cord blood and BM samples using an EasySep™ Human CD34 Positive Selection Kit II (STEMCELL Technologies, Vancouver, Canada); sample purity of >95% was confirmed using flow cytometry ...
-
bioRxiv - Microbiology 2020Quote: Bone marrow-derived primary human CD34+ HSPCs (Stem Cell Technologies) were cultured in erythroid differentiation medium (cPIMDM ...
-
bioRxiv - Genomics 2020Quote: ... CD34+ human cord blood cells were obtained from StemCell Technologies, and long-term CD34+ HSPC cultures were established by overexpression of AML1-ETO or AML1-ETO-FKBP12F36V as previously described23 ...
-
bioRxiv - Bioengineering 2021Quote: ... Human iPS cells were cultured in mTeSR1 (StemCell Technologies; 85870) medium without antibiotics and split (1:6 ...
-
bioRxiv - Microbiology 2020Quote: ... Immunocult human CD3/CD28 T cell activator (STEMCELL Technologies, USA) was used to stimulate the PBMCs as a positive control for immunological activation.
-
bioRxiv - Microbiology 2022Quote: ... EasySep™ Human CD14 Positive Selection Kit II (StemCell Technologies) was used ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human EGF (10 ug/mL; Stem Cell Technologies) in 10% DMSO before long-term cryopreservation (1X107 cells/mL ...
-
bioRxiv - Microbiology 2020Quote: Commercial Intesticult (INT) human organoid growth medium (Stem Cell Technologies), composed of components A and B ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Human cord blood CD34+ cells were purchased from STEMCELL Technologies GmbH (Cologne ...
-
bioRxiv - Neuroscience 2020Quote: ... Human iPSCs were maintained in complete mTeSR1 medium (STEMCELL Technologies) on Matrigel (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... Primary human peripheral blood CD8+ T cells (Stemcell Technologies - #70027) were expanded using fresh complete ImmunoCult™-XF T Cell Expansion Medium (Stemcell Technologies - #10981 ...
-
bioRxiv - Genetics 2021Quote: ... or ReLeSR Human Pluripotent Stem Cell Passaging Reagent (STEMCELL Technologies), and maintained on media supplemented with the ROCK1 inhibitor Y-27632 (10 µM ...